Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) is -60.38% lower on its value in year-to-date trading and has touched a low of $0.62 and a high of $2.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LXRX stock was last observed hovering at around $0.70 in the last trading session, with the day’s loss setting it -0.41%.
Currently trading at $0.29, the stock is -58.26% and -61.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 61.39 million and changing -58.17% at the moment leaves the stock -79.00% off its SMA200. LXRX registered -88.83% loss for a year compared to 6-month loss of -82.99%.
The stock witnessed a -64.29% gain in the last 1 month and extending the period to 3 months gives it a -64.33%, and is -58.33% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 20.24% over the week and 12.17% over the month.
Lexicon Pharmaceuticals Inc (LXRX) has around 285 employees, a market worth around $105.77M and $5.23M in sales. Profit margin for the company is -4109.41%. Distance from 52-week low is -52.84% and -89.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.91%).
with sales reaching $6.48M over the same period.The EPS is expected to grow by 14.05% this year, but quarterly earnings will post 824.52% year-over-year. Quarterly sales are estimated to grow 822.99% in year-over-year returns.
Lexicon Pharmaceuticals Inc (LXRX) Top Institutional Holders
The shares outstanding are 361.49M, and float is at 179.90M with Short Float at 24.87%.
The top institutional shareholder in the company is ARTAL GROUP S.A. with over 175.1 million shares valued at $294.17 million. The investor’s holdings represent 56.3318% of the LXRX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 38.69 million shares valued at $64.99 million to account for 15.7656 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.89 million shares representing 4.0304% and valued at over $16.62 million, while VANGUARD GROUP INC holds 3.1277 of the shares totaling 7.68 million with a market value of $12.89 million.
Lexicon Pharmaceuticals Inc (LXRX) Insider Activity
A total of 0 insider transactions have happened at Lexicon Pharmaceuticals Inc (LXRX) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Lexicon Pharmaceuticals Inc (LXRX): Who are the competitors?
The company’s main competitors (and peers) include Thermo Fisher Scientific Inc. (TMO) that is trading -9.97% down over the past 12 months. Ligand Pharmaceuticals Inc. (LGND) that is 47.06% higher over the same period.
